NEUPENTINE

(GABAPENTINE)

LAUNCH PLAN
QUETTA
DISTRICT

BY: - SHERAZ PERVAIZ

(Senior sales promotion officer)
Quetta.

WORLD WIDE AVALIABILITY:-

PRODUCTS GABAPENTINE

RESEARCH NEUROTIN

COMPANY PFIZER

STRENGTH CAP 100mg, 300mg, 400mg

AVALIABLE TAB 600mg, 800mg
Oral solution 250mg\5ml
 ALL READY EXISTING MAJOR
BRANDS:-

SR
BRAND LAUCHING
COMPANY STRENGTHS PRIZES
NAME MONTH’S
NO

100mg 89/=
01 NEOGAB HILTON 300mg 189/= APRIL-2004
400mg 220/=

100mg 240/=
ZAKA HEALTH 300mg 540/=
02 GABTINE
CARE 400mg 690/=
APRIL-05
All strengths are available in a
pack of 30’s

100mg 50/=
03 GABAPLUS PLATINIUM 300mg 150/= JUNE-05
400mg 200/=

100mg 75/=
RECENTLY
04 GLOREX DYSON 300mg 150/=
LAUNCHED
400mg 215/=
MARKET SHARE GABAPENTINES
(QUETTA)

GABATIN GABAPLUS
1.50% 0.50%

NEOGAB
98%

NEOGAB GABATIN GABAPLUS

 NEOGAB’S MARKET SHARE DETAILS
(MICROANALYSIS):-

%AGE

QUETTA 79.3%
PISHIN 3.0%
CHAMAN 3.4%
LORALAI 4.0%
ZHOB 2.5%
KHUZDAR 3.5%
OTHERS 4.3%

CHAMAN 3.40%

KHUZDAR 3.50% OTHERS 4.30%

ZHOB 2.50%
LORALAI 4%

PISHIN 3.00%

QUETTA 79%

QUETTA PISHIN CHAMAN LORALAI

ZHOB KHUZDAR OTHERS
 MAJOR PRESCRIBER’S
NEOGAB:-
1. DR. GHULAM HAIDER
2. DR. NAQEEB ULLAH
3. DR. SALEEM BARACH
4. DR. RAZ MUHAMMAD
5. DR. NADIR KHAN
6. DR. IQBAL CHAUHDARY
7. DR. NASEEB ULLAH SHAH
8. DR. JAVAID AFZAL
9. DR. JAHANZAIB KHAN
10. DR. SAMAD ALI
11. DR. M. IRFAN
12. DR. NAUROZ ALI
13. DR. GHULAM RASOOL
14. DR. ESSA KHAN
15. DR. KHALID SHAH
16. DR. PARKASH LAL
17. DR. INAM SHABBIR
18. DR. HAQDAD TAREEN
19. DR. INAYAT ULLAH KHAN
20. DR. SHAMEEMA HANIF
21. DR. MASOOD QAZI
22. DR. SALEH TAREEN
23. DR.NASIR KHAN
24. DR. M. ANWAR
25. DR. M. ALI
26. DR. A. MANAN
27. DR. WALI MUHAMMAD
28. DR.HAMEEDULLAH BUZDAR
29. DR.ZAFAR AHMED.
PROMOTIONAL ACTIVITIES NEOGAB
2005:-

1. LSP ORTHO SERENA HOTEL QUETTA

2. LSP NEURO SERENA HOTEL QUETTA

3. P. PRESENTATION CMH QUETTA

4. GIVE AWAYS (REGULARLY)

5. WARD PRESENTATION MED-CIVIL HOSP

QUETTA

6. WARD PRESENTATION – BMC – QUETTA

7. PSYCATERY WARD ACTIVITIES

8. PERSONAL OBLIGATIONS
NEUPENTINE
(GABAPENTINE)

BEGINS WHERE NATURE

LEAVES…
 NEUPENTINE (GABAPENTINE)
PRE LAUNCH WORK:-

1. ALL NEOGAB PRESCRIBERS ARE ALREADY O

LIST AND REGULARLY VISITED IN THE
PREVIOUS MONTHS.

2. MIND MAPING HAVE BEEN DONE WITH A

DIALOGUE “SOON WE ARE COMING WITH A
NEW PRODUCT OF YOUR SPECIALITY”

3. ALL SPOTS OF NOT ONLY GABAPENTINES

BUT OF OTHER ANTI- EPILEPTE AGENTS AND
OTHER PRODUCTS FOR NEUROPATHIC PAIN
HAVE BEEN IDENTIFIED.

4. MAJOR SPOTS OF NEOGAB HAVE BEEN

TARGETTED WITH ALL FEED BACK

5. FEW NEW CUSTOMERS (WHERE NO ANY

GABAPENTINE BRAND HAVE BEEN
INTRODUCED) HAVE BEEN TARGETTED
 POST LAUNCH ACTION
PLAN:-
 AS MAJOR SHARE OF GABAPENTINE IS WITH
NEOGAB (HILTON) NO DOUBT THAT HILTON
HAVE A GOOD ACADEMIC REPUTATION.
 THIS IS A TECHNICAL PRODUCT ONLY THOSE
COMPANIES WHO HAVE A GOOD ACADEMIC
BACKGROUND CAN SNATCH THE MARKET
SHARE.
 HIGHNOON IS ONE OF THAT COMPANIES
WHICH HAVE A GOOD ACEDAMIC
REPUTATION AND THIS IS OUR STRENGTH
FOR NEUPENTINE.
 TWO T.M’S OF HILTON
ARE PROMOTING NEOGAB IN QUETTA BOTH
OF THESE TWO PERSONS HAVE NOT A GOOD
FOOT WORK.
 THIS IS THE POINT WHERE WE CAN HIT
 WE CAN SNATCH THEIR SHARES WITH OUR
PROPER FOOTING.
 WE SHALL PROMOTE THIS PRODUCT ON A
SCIENTIFIC GROUND.
 WE SHALL NOT ONLY RELAY ON NEOGAB
CUSTOMERS BUT WE HAVE TO ALSO
CULTIVATE NEW CUSTOMERS FOR
NEUPENTINE.
 JULY-2005

ONLY QUETTA

PHSYCATERY BMC LAUNCH

NEURO WARD BMC CAKE CUTTING

AUGUST-2005

KHUZDAR, PISHIN, DALBANDIN, ZHOB

LORALAI, DUKKI, CHAMAN, KHU/SRN

ANY SCIENTIFIC ACTIVITY QUETTA

SEPTEMBER-2005

FEEDBACK & MARKET SURVAY OUT STATION

FEEDBACK AND MARKET SURVAY QUETTA

TARGET THE WEAK AREA’S

 !
Attention

CHANCE
FAVOURS
THE
PREPARED
MIND.
(LOUIS PASTURE)
 HEAD OFFICE
SUPPORT:

 ACADEMIC ACTIVITIES FOR QUETTA

RIGHT AT THE LAUNCHING PHASE.

 SPECIAL BUDGETS TO LANUCH

NEUPENTINE WITH A CELEBRATION AT
NEURO, ORTHO, PSYCHATERY, MEDICINE
AND ONCHOLOGY WARDS.

 PRODUCT MANAGEMENTS VISITS.

 ATTRECTIVE SPECIAL INCENTIVE PLANS.

THANK
YOU